# A Study of the Safety, Tolerability, and Pharmacokinetics of Orally Administered Venglustat and Itraconazole in Healthy Adult Male Participants

> **NCT06421714** · PHASE1 · COMPLETED · sponsor: **Genzyme, a Sanofi Company** · enrollment: 8 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Venglustat
- **DRUG:** Itraconazole

## Key facts

- **NCT ID:** NCT06421714
- **Lead sponsor:** Genzyme, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-16
- **Primary completion:** 2018-10-14
- **Final completion:** 2018-10-14
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2024-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06421714

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06421714, "A Study of the Safety, Tolerability, and Pharmacokinetics of Orally Administered Venglustat and Itraconazole in Healthy Adult Male Participants". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT06421714. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*